Carol J Farhangfar

8PUBLICATIONS
63CO-AUTHORS
Molecular targetsPlanning and decision makingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 13, 2026
Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

|Jun 01, 2026
Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer.

|May 20, 2024
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based Immunotherapies.

Kirk D Beebe, Joel R Eisner, John Guo

|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont Study.

Joel R Eisner, Gregory M Mayhew, James M Davison

|Mar 16, 2023
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer.

Joel R Eisner, Kirk D Beebe, Gregory M Mayhew

|Jul 15, 2022
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.

Carol J Farhangfar, Gregory T Scarola, Victoria A Morris

Pageof 2

Frequent Collaborators

4 joint publications

Kathryn F Mileham

3 joint publications

Yuelong Guo

2 joint publications

Joel R Eisner

2 joint publications

Kirk D Beebe